No abstract

risks subthemes included side effects (n=42), risk and benefit tradeoff (n=26); barriers subthemes included financial burden/unaffordability (n=32), fair access to medications (n=29); alternative treatments to prescriptions subthemes included diet modifications (n=34), dietary supplements (n=31); condition characteristics subthemes included substantial symptom heterogeneity (n=30); and future treatment needs subthemes included need for additional therapies (n=36), treatment with less side effects (n=29), and need for disease modifying treatment (n=25). Conclusions: Examination across diverse VoP reports provides insights across diverse patient populations and illnesses on patient-experiences. Common themes emerged that can help stakeholders understand the symptoms, impacts, and challenges patients face. These findings can be useful in medical-product development and value assessment.